India Proposes Instant Drug Licence Suspension
India proposed rules requiring regulators to immediately suspend manufacturing licences for medicines failing quality tests. The move aims to eliminate public health risks by removing defective drugs from circulation faster.
Xurve View
Insights:
Xurve View
India proposed instant manufacturing licence suspensions for drug makers whose products fail government quality tests. The draft rules remove due-process delays to curb public-health risks from substandard medicines. The ministry aims to tighten oversight across one of the world's largest pharmaceutical sectors following fatal overseas incidents involving local syrups.
